STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 322.41 Million USD | 13.37% |
| 2022 | 284.39 Million USD | 23.4% |
| 2021 | 230.47 Million USD | 41.0% |
| 2020 | 163.46 Million USD | 8.84% |
| 2019 | 150.18 Million USD | 21.16% |
| 2018 | 123.95 Million USD | 36.8% |
| 2017 | 90.61 Million USD | 9.92% |
| 2016 | 82.43 Million USD | 6.88% |
| 2015 | 77.12 Million USD | 2.85% |
| 2014 | 74.98 Million USD | 3.84% |
| 2013 | 72.21 Million USD | 13.22% |
| 2012 | 63.78 Million USD | 1.62% |
| 2011 | 62.76 Million USD | 14.21% |
| 2010 | 54.95 Million USD | -27.06% |
| 2009 | 75.34 Million USD | 0.6% |
| 2008 | 74.89 Million USD | 26.16% |
| 2007 | 59.36 Million USD | 5.47% |
| 2006 | 56.28 Million USD | 9.71% |
| 2005 | 51.3 Million USD | -0.74% |
| 2004 | 51.68 Million USD | 2.43% |
| 2003 | 50.45 Million USD | 4.58% |
| 2002 | 48.24 Million USD | -3.96% |
| 2001 | 50.23 Million USD | -6.94% |
| 2000 | 53.98 Million USD | -8.5% |
| 1999 | 59 Million USD | 8.86% |
| 1998 | 54.2 Million USD | 27.53% |
| 1997 | 42.5 Million USD | 0.71% |
| 1996 | 42.2 Million USD | 21.61% |
| 1995 | 34.7 Million USD | 26.64% |
| 1994 | 27.4 Million USD | 36.32% |
| 1993 | 20.1 Million USD | 97.06% |
| 1992 | 10.2 Million USD | 137.21% |
| 1991 | 4.3 Million USD | -4.44% |
| 1990 | 4.5 Million USD | 0.0% |
| 1989 | 4.5 Million USD | -33.82% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 77.35 Million USD | 1.42% |
| 2024 Q2 | 99 Million USD | 27.99% |
| 2024 Q3 | 88.59 Million USD | -10.52% |
| 2023 Q3 | 80.3 Million USD | -13.0% |
| 2023 FY | 322.41 Million USD | 13.37% |
| 2023 Q4 | 76.27 Million USD | -5.02% |
| 2023 Q1 | 73.52 Million USD | 14.81% |
| 2023 Q2 | 92.3 Million USD | 25.54% |
| 2022 Q3 | 76.04 Million USD | -6.23% |
| 2022 FY | 284.39 Million USD | 23.4% |
| 2022 Q1 | 63.2 Million USD | 7.12% |
| 2022 Q2 | 81.1 Million USD | 28.32% |
| 2022 Q4 | 64.04 Million USD | -15.78% |
| 2021 Q1 | 50.75 Million USD | 10.34% |
| 2021 Q2 | 62.36 Million USD | 22.89% |
| 2021 FY | 230.47 Million USD | 41.0% |
| 2021 Q3 | 58.35 Million USD | -6.44% |
| 2021 Q4 | 59 Million USD | 1.11% |
| 2020 FY | 163.46 Million USD | 8.84% |
| 2020 Q2 | 35.19 Million USD | 0.02% |
| 2020 Q3 | 47.08 Million USD | 33.78% |
| 2020 Q4 | 45.99 Million USD | -2.3% |
| 2020 Q1 | 35.18 Million USD | -9.51% |
| 2019 Q2 | 39.66 Million USD | 21.73% |
| 2019 Q1 | 32.58 Million USD | 4.48% |
| 2019 FY | 150.18 Million USD | 21.16% |
| 2019 Q4 | 38.88 Million USD | -0.44% |
| 2019 Q3 | 39.05 Million USD | -1.54% |
| 2018 Q4 | 31.18 Million USD | -1.84% |
| 2018 Q2 | 33.9 Million USD | 25.14% |
| 2018 Q1 | 27.09 Million USD | 9.02% |
| 2018 FY | 123.95 Million USD | 36.8% |
| 2018 Q3 | 31.77 Million USD | -6.3% |
| 2017 FY | 90.61 Million USD | 9.92% |
| 2017 Q4 | 24.85 Million USD | 5.87% |
| 2017 Q3 | 23.47 Million USD | 7.01% |
| 2017 Q2 | 21.93 Million USD | 7.79% |
| 2017 Q1 | 20.35 Million USD | -8.07% |
| 2016 Q4 | 22.13 Million USD | 10.4% |
| 2016 Q1 | 19.26 Million USD | -7.62% |
| 2016 Q2 | 20.97 Million USD | 8.85% |
| 2016 FY | 82.43 Million USD | 6.88% |
| 2016 Q3 | 20.05 Million USD | -4.4% |
| 2015 Q1 | 18.85 Million USD | 13.79% |
| 2015 Q3 | 18.75 Million USD | 0.5% |
| 2015 FY | 77.12 Million USD | 2.85% |
| 2015 Q4 | 20.85 Million USD | 11.24% |
| 2015 Q2 | 18.65 Million USD | -1.07% |
| 2014 Q3 | 18.18 Million USD | -9.28% |
| 2014 Q1 | 20.17 Million USD | 6.51% |
| 2014 Q2 | 20.04 Million USD | -0.64% |
| 2014 FY | 74.98 Million USD | 3.84% |
| 2014 Q4 | 16.57 Million USD | -8.88% |
| 2013 Q4 | 18.94 Million USD | 10.74% |
| 2013 FY | 72.21 Million USD | 13.22% |
| 2013 Q1 | 18 Million USD | 9.32% |
| 2013 Q2 | 18.16 Million USD | 0.91% |
| 2013 Q3 | 17.1 Million USD | -5.82% |
| 2012 Q2 | 15.94 Million USD | 2.79% |
| 2012 Q1 | 15.5 Million USD | -5.32% |
| 2012 Q4 | 16.46 Million USD | 3.78% |
| 2012 Q3 | 15.86 Million USD | -0.48% |
| 2012 FY | 63.78 Million USD | 1.62% |
| 2011 FY | 62.76 Million USD | 14.21% |
| 2011 Q3 | 15.26 Million USD | -6.17% |
| 2011 Q2 | 16.26 Million USD | 9.56% |
| 2011 Q4 | 16.38 Million USD | 7.3% |
| 2011 Q1 | 14.84 Million USD | 3.2% |
| 2010 Q2 | 13.63 Million USD | -1.01% |
| 2010 FY | 54.95 Million USD | -27.06% |
| 2010 Q4 | 14.38 Million USD | 9.41% |
| 2010 Q3 | 13.15 Million USD | -3.57% |
| 2010 Q1 | 13.77 Million USD | -30.52% |
| 2009 Q1 | 18.28 Million USD | 0.69% |
| 2009 FY | 75.34 Million USD | 0.6% |
| 2009 Q4 | 19.83 Million USD | 9.48% |
| 2009 Q3 | 18.11 Million USD | -5.25% |
| 2009 Q2 | 19.11 Million USD | 4.56% |
| 2008 FY | 74.89 Million USD | 26.16% |
| 2008 Q1 | 17.96 Million USD | 13.06% |
| 2008 Q2 | 20.66 Million USD | 15.06% |
| 2008 Q3 | 18.11 Million USD | -12.35% |
| 2008 Q4 | 18.15 Million USD | 0.25% |
| 2007 FY | 59.36 Million USD | 5.47% |
| 2007 Q1 | 14.91 Million USD | -2.29% |
| 2007 Q2 | 14.93 Million USD | 0.1% |
| 2007 Q3 | 13.62 Million USD | -8.73% |
| 2007 Q4 | 15.88 Million USD | 16.55% |
| 2006 Q4 | 15.26 Million USD | 16.2% |
| 2006 FY | 56.28 Million USD | 9.71% |
| 2006 Q3 | 13.13 Million USD | -9.77% |
| 2006 Q1 | 13.31 Million USD | 10.34% |
| 2006 Q2 | 14.56 Million USD | 9.36% |
| 2005 Q4 | 12.06 Million USD | 3.61% |
| 2005 FY | 51.3 Million USD | -0.74% |
| 2005 Q2 | 13.91 Million USD | 1.7% |
| 2005 Q3 | 11.64 Million USD | -16.27% |
| 2005 Q1 | 13.67 Million USD | -1.96% |
| 2004 Q2 | 12.02 Million USD | -11.39% |
| 2004 Q4 | 13.95 Million USD | 14.93% |
| 2004 Q1 | 13.56 Million USD | 6.39% |
| 2004 FY | 51.68 Million USD | 2.43% |
| 2004 Q3 | 12.14 Million USD | 0.96% |
| 2003 Q2 | 12.95 Million USD | 1.35% |
| 2003 FY | 50.45 Million USD | 4.58% |
| 2003 Q1 | 12.77 Million USD | -3.39% |
| 2003 Q3 | 11.92 Million USD | -7.91% |
| 2003 Q4 | 12.75 Million USD | 6.93% |
| 2002 Q3 | 11.2 Million USD | -7.34% |
| 2002 Q1 | 11.73 Million USD | -3.77% |
| 2002 Q2 | 12.08 Million USD | 3.04% |
| 2002 FY | 48.24 Million USD | -3.96% |
| 2002 Q4 | 13.22 Million USD | 18.1% |
| 2001 Q3 | 12.15 Million USD | -5.71% |
| 2001 Q1 | 13 Million USD | -2.51% |
| 2001 Q2 | 12.89 Million USD | -0.85% |
| 2001 FY | 50.23 Million USD | -6.94% |
| 2001 Q4 | 12.19 Million USD | 0.3% |
| 2000 Q3 | 13.66 Million USD | 6.35% |
| 2000 Q4 | 13.33 Million USD | -2.4% |
| 2000 FY | 53.98 Million USD | -8.5% |
| 2000 Q2 | 12.84 Million USD | -9.12% |
| 2000 Q1 | 14.13 Million USD | -9.37% |
| 1999 Q3 | 13.8 Million USD | -6.12% |
| 1999 FY | 59 Million USD | 8.86% |
| 1999 Q4 | 15.6 Million USD | 13.04% |
| 1999 Q2 | 14.7 Million USD | -0.68% |
| 1999 Q1 | 14.8 Million USD | 12.12% |
| 1998 Q1 | 14.1 Million USD | 65.88% |
| 1998 FY | 54.2 Million USD | 27.53% |
| 1998 Q4 | 13.2 Million USD | 2.33% |
| 1998 Q3 | 12.9 Million USD | -7.86% |
| 1998 Q2 | 14 Million USD | -0.71% |
| 1997 Q3 | 11.8 Million USD | 1.72% |
| 1997 Q4 | 8.5 Million USD | -27.97% |
| 1997 Q2 | 11.6 Million USD | 12.62% |
| 1997 FY | 42.5 Million USD | 0.71% |
| 1997 Q1 | 10.3 Million USD | -10.43% |
| 1996 FY | 42.2 Million USD | 21.61% |
| 1996 Q4 | 11.5 Million USD | 6.48% |
| 1996 Q3 | 10.8 Million USD | 4.85% |
| 1996 Q2 | 10.3 Million USD | 8.42% |
| 1996 Q1 | 9.5 Million USD | -5.0% |
| 1995 Q2 | 8.4 Million USD | 15.07% |
| 1995 FY | 34.7 Million USD | 26.64% |
| 1995 Q4 | 10 Million USD | 11.11% |
| 1995 Q3 | 9 Million USD | 7.14% |
| 1995 Q1 | 7.3 Million USD | -9.88% |
| 1994 FY | 27.4 Million USD | 36.32% |
| 1994 Q1 | 5.8 Million USD | -6.45% |
| 1994 Q2 | 6.6 Million USD | 13.79% |
| 1994 Q3 | 6.9 Million USD | 4.55% |
| 1994 Q4 | 8.1 Million USD | 17.39% |
| 1993 Q3 | 4.7 Million USD | -6.0% |
| 1993 Q4 | 6.2 Million USD | 31.91% |
| 1993 Q2 | 5 Million USD | 16.28% |
| 1993 Q1 | 4.3 Million USD | 22.86% |
| 1993 FY | 20.1 Million USD | 97.06% |
| 1992 Q1 | 2 Million USD | 11.11% |
| 1992 Q4 | 3.5 Million USD | 45.83% |
| 1992 FY | 10.2 Million USD | 137.21% |
| 1992 Q3 | 2.4 Million USD | 4.35% |
| 1992 Q2 | 2.3 Million USD | 15.0% |
| 1991 Q4 | 1.8 Million USD | 125.0% |
| 1991 Q1 | 800 Thousand USD | 108.42% |
| 1991 Q2 | 900 Thousand USD | 12.5% |
| 1991 FY | 4.3 Million USD | -4.44% |
| 1991 Q3 | 800 Thousand USD | -11.11% |
| 1990 FY | 4.5 Million USD | 0.0% |
| 1990 Q1 | 6.2 Million USD | 416.67% |
| 1990 Q2 | 6.3 Million USD | 1.61% |
| 1990 Q4 | -9.5 Million USD | -733.33% |
| 1990 Q3 | 1.5 Million USD | -76.19% |
| 1989 Q4 | 1.2 Million USD | 9.09% |
| 1989 Q1 | 1.1 Million USD | -35.29% |
| 1989 Q2 | 1.1 Million USD | 0.0% |
| 1989 Q3 | 1.1 Million USD | 0.0% |
| 1989 FY | 4.5 Million USD | -33.82% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -233.649% |
| AngioDynamics, Inc. | 303.91 Million USD | -6.088% |
| AtriCure, Inc. | 399.24 Million USD | 19.244% |
| Avinger, Inc. | 7.65 Million USD | -4113.474% |
| Azenta, Inc. | 665.07 Million USD | 51.522% |
| BioLife Solutions, Inc. | 143.27 Million USD | -125.039% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 91.027% |
| Daxor Corporation | 1.28 Million USD | -25078.541% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -1663.855% |
| Femasys Inc. | 1.07 Million USD | -29976.868% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -187.229% |
| Hologic, Inc. | 4.03 Billion USD | 92.0% |
| ICU Medical, Inc. | 2.25 Billion USD | 85.728% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 95.474% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -1030.58% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -66.637% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -27875.781% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -27875.781% |
| Masimo Corporation | 2.04 Billion USD | 84.258% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -232.048% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 74.358% |
| Nephros, Inc. | 14.23 Million USD | -2164.468% |
| NovoCure Limited | 509.33 Million USD | 36.699% |
| NEXGEL, Inc. | 4.08 Million USD | -7784.935% |
| NEXGEL, Inc. | 4.08 Million USD | -7784.935% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -10975.747% |
| OraSure Technologies, Inc. | 405.47 Million USD | 20.484% |
| Pro-Dex, Inc. | 53.84 Million USD | -498.795% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -18012.256% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -1587.652% |
| QuidelOrtho Corporation | 2.99 Billion USD | 89.245% |
| Repligen Corporation | 638.76 Million USD | 49.525% |
| Sanara MedTech Inc. | 64.98 Million USD | -396.101% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -541.954% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 91.868% |
| Jin Medical International Ltd. | 19.82 Million USD | -1526.596% |